Roth Capital analyst Chip Moore raised the firm's price target on Hyster-Yale to $44 from $40 and keeps a Buy rating on the shares after its Q4 results. The firm is looking for strategic initiatives underway to drive improving sentiment into FY27, adding that while significant challenges remain, Roth continues to believe this is an attractive GDP-plus-type grower with solid long-term growth prospects, the analyst tells investors in a research note.
